FUMINOBU OKUGUCHI

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 203 citations

Medicine, Pharmacology, Pharmacotherapy +15

Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002–2011 in <scp>J</scp>apan (<scp>JDDM</scp>32)

Mariko Oishi, Katsuya Yamazaki, FUMINOBU OKUGUCHI et al. · Journal of Diabetes Investigation · 2013 · 91 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Association between Body Mass Index and Core Components of Metabolic Syndrome in 1486 Patients with Type 1 Diabetes Mellitus in Japan (JDDM 13)

Keiko Arai, Hiroki Yokoyama, FUMINOBU OKUGUCHI et al. · Endocrine Journal · 2008 · 31 citations · Full text

Medicine, Endocrinology, Internal Medicine +12

Vascular complications and long-term administration of oral hypoglycemic agents in patients with diabetes mellitus.

Akira Ohneda, Yoshisuke Maruhama, Hiroshi Itabashi et al. · The Tohoku Journal of Experimental Medicine · 1978 · 26 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Disturbances of the alimentary tract motility and hypermotilinemia in the patients with diabetes mellitus.

Chiyuki Nakanome, Hiroaki Akai, Michio Hongo et al. · The Tohoku Journal of Experimental Medicine · 1983 · 21 citations · Full text

Medicine, Endocrinology, Physiology +17